3,4-dihydroxyphenylacetaldehyde has been researched along with nad in 2 studies
| Studies (3,4-dihydroxyphenylacetaldehyde) | Trials (3,4-dihydroxyphenylacetaldehyde) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetaldehyde) | Studies (nad) | Trials (nad) | Recent Studies (post-2010) (nad) |
|---|---|---|---|---|---|
| 99 | 0 | 50 | 30,121 | 88 | 5,663 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacKerell, AD; Pietruszko, R | 1 |
| Fernandez, E; Goldstein, DS; Martinez, PA; Strong, R; Sullivan, P; Wey, MC | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and nad
| Article | Year |
|---|---|
Chemical modification of human aldehyde dehydrogenase by physiological substrate.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Chemical Phenomena; Chemistry, Physical; Chloral Hydrate; Circular Dichroism; Humans; Isoenzymes; Kinetics; NAD; Phenylacetates | 1987 |
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Body Weight; Cognition Disorders; Cytosol; Disease Models, Animal; Dopamine; Female; Genotype; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Parkinson Disease; Time Factors; Tyrosine 3-Monooxygenase | 2012 |